243 results on '"Zabor, Emily C."'
Search Results
2. Using the Electronic Health Record to Develop a Gastric Cancer Risk Prediction Model
3. Small Choroidal Melanoma: Outcomes After Surveillance Versus Immediate Treatment
4. Iris freckle: a distinct entity.
5. Predictive model for iris melanoma.
6. Identification of robust deep neural network models of longitudinal clinical measurements
7. Conditional Survival in Uveal Melanoma
8. Does Reduced Renal Function Predispose to Cancer-specific Mortality from Renal Cell Carcinoma?
9. Survival Outcomes for Metaplastic Breast Cancer Differ by Histologic Subtype
10. Unsupervised clustering of longitudinal clinical measurements in electronic health records.
11. Neoadjuvant Gemcitabine-Cisplatin Plus Radical Cystectomy-Pelvic Lymph Node Dissection for Muscle-invasive Bladder Cancer: A 12-year Experience
12. Feasibility of Breast-Conservation Therapy and Hypofractionated Radiation in the Setting of Prior Breast Augmentation
13. Guidelines for Reporting of Figures and Tables for Clinical Research in Urology
14. Prediagnostic serum polychlorinated biphenyl concentrations and primary liver cancer: A case-control study nested within two prospective cohorts
15. Randomized Controlled Trials
16. Does Use of Neoadjuvant Chemotherapy Affect the Decision to Pursue Fertility Preservation Options in Young Women with Breast Cancer?
17. Communicating cardiovascular risk to high-risk cancer survivors: a mixed-methods pilot study of a statin risk communication tool
18. Do Body Mass Index and Breast Density Impact Cancer Risk Among Women with Lobular Carcinoma In Situ?
19. The Tyrer–Cuzick Model Inaccurately Predicts Invasive Breast Cancer Risk in Women With LCIS
20. Contralateral Prophylactic Mastectomy Use After Neoadjuvant Chemotherapy
21. Increase in Utilization of Nipple-Sparing Mastectomy for Breast Cancer: Indications, Complications, and Oncologic Outcomes
22. Axillary management for young women with breast cancer varies between patients electing breast-conservation therapy or mastectomy
23. Characterization and Impact of TERT Promoter Region Mutations on Clinical Outcome in Renal Cell Carcinoma
24. Genomic Differences Between “Primary” and “Secondary” Muscle-invasive Bladder Cancer as a Basis for Disparate Outcomes to Cisplatin-based Neoadjuvant Chemotherapy
25. The Effect of Patient and Surgical Characteristics on Renal Function After Partial Nephrectomy
26. Long-Term Renal Function Recovery following Radical Nephrectomy for Kidney Cancer: Results from a Multicenter Confirmatory Study
27. Impact of Age on Locoregional and Distant Recurrence After Mastectomy for Ductal Carcinoma In Situ With or Without Microinvasion
28. Is Clinical Exam of the Axilla Sufficient to Select Node-Positive Patients Who Downstage After NAC for SLNB? A Comparison of the Accuracy of Clinical Exam Versus MRI
29. Does Breast Density Increase the Risk of Re-excision for Women with Breast Cancer Having Breast-Conservation Therapy?
30. Risk of Contralateral Breast Cancer in Women with Ductal Carcinoma In Situ Associated with Synchronous Ipsilateral Lobular Carcinoma In Situ
31. Was Reexcision Less Frequent for Patients with Lobular Breast Cancer After Publication of the SSO-ASTRO Margin Guidelines?
32. Lobular Histology Does Not Predict the Need for Axillary Dissection Among ACOSOG Z0011-Eligible Breast Cancers
33. A Comparison of Patient-Reported Outcomes After Breast-Conserving Surgery and Mastectomy with Implant Breast Reconstruction
34. Comparison of Local Recurrence Risk Estimates After Breast-Conserving Surgery for DCIS: DCIS Nomogram Versus Refined Oncotype DX Breast DCIS Score
35. Chemoprevention Uptake for Breast Cancer Risk Reduction Varies by Risk Factor
36. Long-Term Outcomes After Surgical Treatment of Malignant/Borderline Phyllodes Tumors of the Breast
37. Differences between screen-detected and interval breast cancers among BRCA mutation carriers
38. Radiation Therapy After Breast-Conserving Surgery in Women 70 Years of Age and Older: How Wisely Do We Choose?
39. Does Lymph Node Status Prior to Neoadjuvant Chemotherapy Influence the Number of Sentinel Nodes Removed?
40. Defining Cancer Subtypes With Distinctive Etiologic Profiles: An Application to the Epidemiology of Melanoma
41. Proceedings of the third international molecular pathological epidemiology (MPE) meeting
42. MRI and Prediction of Pathologic Complete Response in the Breast and Axilla after Neoadjuvant Chemotherapy for Breast Cancer
43. Integration of Recurrent Somatic Mutations with Clinical Outcomes: A Pooled Analysis of 1049 Patients with Clear Cell Renal Cell Carcinoma
44. Efficacy and Toxicity of Intravitreous Chemotherapy for Retinoblastoma: Four-Year Experience
45. Intravoxel incoherent motion (IVIM) histogram biomarkers for prediction of neoadjuvant treatment response in breast cancer patients
46. Influence of Age on the Clinical Outcome of Breast Cancer for Men and the Development of Second Primary Cancers
47. A Comparison of Patient-Reported Outcomes After Nipple-Sparing Mastectomy and Conventional Mastectomy with Reconstruction
48. Variability in Predictions from Online Tools: A Demonstration Using Internet-Based Melanoma Predictors
49. Is Low-Volume Disease in the Sentinel Node After Neoadjuvant Chemotherapy an Indication for Axillary Dissection?
50. Accuracy of Self-reported Smoking Exposure Among Bladder Cancer Patients Undergoing Surveillance at a Tertiary Referral Center
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.